Frontiers in Oncology (Dec 2018)

Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells

  • Xianbin Zhang,
  • Maria Schönrogge,
  • Johanna Eichberg,
  • Edgar Heinz Uwe Wendt,
  • Simone Kumstel,
  • Jan Stenzel,
  • Tobias Lindner,
  • Robert Jaster,
  • Bernd Joachim Krause,
  • Brigitte Vollmar,
  • Dietmar Zechner

DOI
https://doi.org/10.3389/fonc.2018.00590
Journal volume & issue
Vol. 8

Abstract

Read online

In this study we evaluated the interaction of pancreatic cancer cells, cancer-associated fibroblasts, and distinct drugs such as α-cyano-4-hydroxycinnamate, metformin, and gemcitabine. We observed that α-cyano-4-hydroxycinnamate as monotherapy or in combination with metformin could significantly induce collagen I deposition within the stromal reaction. Subsequently, we demonstrated that cancer-associated fibroblasts impaired the anti-proliferation efficacy of α-cyano-4-hydroxycinnamate, metformin and gemcitabine. Interestingly, inhibition of autophagy in these fibroblasts can augment the anti-proliferation effect of these chemotherapeutics in vitro and can reduce the tumor weight in a syngeneic pancreatic cancer model. These results suggest that inhibiting autophagy in cancer-associated fibroblasts may contribute to strategies targeting cancer.

Keywords